InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Wednesday, 06/14/2017 8:03:11 AM

Wednesday, June 14, 2017 8:03:11 AM

Post# of 3833
DSMB meeting - good results on safety

68% patients fully treated
On target to declare topline results in Dec 2017

Galectin Therapeutics Announces Important Milestones towards Completion of NASH CX Trial
https://finance.yahoo.com/news/galectin-therapeutics-announces-important-milestones-123000735.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News